JA Stone
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- J. M. Andrews (3 shared papers)Tomoko Freshwater (2 shared papers)Rik de Greef (2 shared papers)Jeroen Elassaiss‐Schaap (2 shared papers)Malidi Ahamadi (2 shared papers)JA Wagner (2 shared papers)Marian Iwamoto (2 shared papers)Chang Li (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Journal of Clinical Pathology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
JA Stone
12 papers receiving 553 citations
Peers
Comparison fields: 5 of 72
- Virology 103
- Infectious Diseases 229
- Molecular Medicine 41
- Oncology 187
- Pharmacology 89
Countries citing papers authored by JA Stone
This map shows the geographic impact of JA Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Stone more than expected).
Fields of papers citing papers by JA Stone
This network shows the impact of papers produced by JA Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Stone. The network helps show where JA Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside JA Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 139 | |
| 2 | 2016 | 125 | |
| 3 | 2009 | 81 | |
| 4 | 2016 | 68 | |
| 5 | 1988 | 55 | |
| 6 | 1989 | 35 | |
| 7 | 1986 | 26 | |
| 8 | Drug interactions between caspofungin and tacrolimus | 2001 | 19 |
| 9 | 1986 | 18 | |
| 10 | 1989 | 8 | |
| 11 | 1990 | 7 | |
| 12 | 1988 | 2 |
About JA Stone
JA Stone is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Oncology and Clinical Biochemistry, having authored 12 papers that have together received 583 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antifungal resistance and susceptibility (2 papers), Pneumonia and Respiratory Infections (2 papers), HIV/AIDS drug development and treatment (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Virology (103 citations), Infectious Diseases (229 citations), Molecular Medicine (41 citations), Oncology (187 citations) and Pharmacology (89 citations). JA Stone has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include J. M. Andrews, Tomoko Freshwater, Rik de Greef, Jeroen Elassaiss‐Schaap, Malidi Ahamadi, JA Wagner, Marian Iwamoto, Chang Li, Anna Kondic and Marita Prohn. Their work appears in journals such as Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, European Journal of Clinical Microbiology & Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.